Logo.png
Vyant Bio Announces Investor Conference Call and Webcast for the First Quarter 2022
10 mai 2022 16h01 HE | Vyant Bio, Inc.
CHERRY HILL, N.J., May 10, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT) is an innovative biotechnology company reinventing drug discovery for complex...
Vyant Bio Issues Letter to Shareholders
01 mars 2022 08h30 HE | Vyant Bio, Inc.
Cherry Hill, NJ, March 01, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, the “Company”) (Nadsaq:VYNT), is an innovative biotechnology company focused on identifying unique biological...
Logo.png
Vyant Bio to Present at The Benchmark Company Discovery One-on-One Investor Conference
29 nov. 2021 09h15 HE | Vyant Bio, Inc.
Cherry Hill, N.J.,, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, the “Company”) (Nasdaq: VYNT), an emerging global drug discovery company, is rapidly identifying small and large...
Logo.png
Vyant Bio Announces Investor Conference Call and Webcast for the Third Quarter 2021
09 nov. 2021 09h15 HE | Vyant Bio, Inc.
CHERRY HILL, N.J., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), an emerging global drug discovery company, is rapidly identifying small and large...
Logo.png
Vyant Bio Announces Robert T. Fremeau, Jr. Ph.D. as Chief Scientific Officer
26 oct. 2021 08h00 HE | Vyant Bio, Inc.
Cherry Hill, N.J., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), an emerging global drug discovery company identifying small and large molecule...
Logo.png
Vyant Bio Reports First Quarter 2021 Results and Provides Strategic Business Update
17 mai 2021 17h15 HE | Vyant Bio, Inc.
Cherry Hill, N.J., May 17, 2021 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (the “Company”) (Nasdaq: VYNT), is an innovative biotechnology company focused on partnering with pharmaceutical and other...
Logo.png
Vyant Bio Announces Investor Conference Call and Webcast for First Quarter 2021
13 mai 2021 08h00 HE | Vyant Bio, Inc.
CHERRY HILL, N.J., May 13, 2021 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), is focused on integrating human-powered scientific and technology-based systems to...
Logo.png
Vyant Bio Announces Newly Appointed Board of Directors
05 avr. 2021 16h20 HE | Vyant Bio, Inc.
CHERRY HILL, N.J., April 05, 2021 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (the “Company”) (Nasdaq: VYNT), is a new force in drug discovery, focused on integrating human-powered scientific and...
Logo.png
Cancer Genetics and StemoniX Announce Merger Closing
31 mars 2021 06h30 HE | Cancer Genetics, Inc.
Cancer Genetics, Inc. Renamed to Vyant Bio, Inc. Vyant Bio, Inc. will begin trading on Nasdaq under the symbol VYNT CHERRY HILL, N.J., March 31, 2021 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc....
Old Logo.png
Cancer Genetics Announces Shareholder Approval of All Proposals in Connection with the Proposed Merger with StemoniX
25 mars 2021 09h15 HE | Cancer Genetics, Inc.
Combined entity creates an innovative platform to de-risk and accelerate the discovery and development of preclinical and clinical pipelines with biopharma partners as well as the proprietary pipeline...